Code Compliance Committee
We support our member companies to comply with relevant laws and regulations, guidelines and voluntary codes, and to fulfill their social responsibilities with high ethical standards as members of life-related industries. It also promotes activities as the committee in charge of the "Guidelines for Marketing Information Provision Activities of Ethical Drugs".
Notices and Updates
-
Code Compliance Committee
Updated "FAQs related to changes in the industry standard manual "EDI Uniform Data Format" and JD-NET 8th system renewal.
-
Code Compliance Committee
Report on "FY2025 Meeting of Code Administration Managers and Practitioners" is now available.
-
Code Compliance Committee
JPMA Code of Practice (Revised May 2025)" Book Issued
-
Code Compliance Committee
The article by Chairperson Ouchi of the Code Compliance Promotion Committee was published in the "Nikkan Yakugyo" section of the "Toward the Age of Co-Creation" <7>.
-
Code Compliance Committee
Transparency Guideline for the Relation between Corporate Activities and Medical Institutions" for the payment of FY2024 has been updated.
Contents of Code Compliance Committee
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
JPMA Charter of Corporate Behavior
JPMA established the "JPMA Charter of Corporate Behavior" in 1997 to help member companies fulfill their mission as pharmaceutical companies.
-
JPMA Code of Practice
The JPMA Code of Practice covers all directors and employees of member companies and their interactions with researchers, medical professionals, patient groups, etc.
-
Transparency Guideline for the Relation between Corporate Activities and Medical Institutions
Transparency Guideline for the Relation between Corporate Activities and Medical Institutions is explained.
-
Review Board of Ethical Drug Product Information Brochure
Priority Issues of the Review Board of Ethical Drug Product Information Brochure are described.
-
Communication on GL for Sales Information Provision Activities
Information on "Guidelines for Marketing Information Provision Activities for Ethical Drugs" as an oversight committee is posted.
-
Announcement from Code Compliance Committee
Various announcements from the Code Compliance Committee are posted.